Epitopes on Ki antigen and its association to autoantibody production.

Ki 抗原上的表位及其与自身抗体产生的关联。

基本信息

  • 批准号:
    04670396
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1994
  • 项目状态:
    已结题

项目摘要

A cDNA coding for a nuclear autoantigen, Ki, has been cloned previously and we have found that Ki has an amino acid sequence which is homologous to SV 40 large T antigen nuclear localization sign (SV 40 NLS). We studied whether the amino acid sequence which is homologous to SV 40 NMS is one of the epitopes on Ki antigen and anti-Ki antibody croos-react with SV 40 large T antigen.Forty-nine anti-Ki positive sera were selected from 250 patients with systemic lupus erythematosus (SLE) by enzyme-linked immunosorbent assay (ELISA) using recombinant Ki (bNAX) as an antigne. A 16-mer Ki synthetic peptide that had a sequence homologous to SV 40 NLS (KILT) was prepared. In addition, 4 different synthetic peptides (KISP1-4) were prepared based on the analysis of conformational profile and hydoropathy of Ki antigen. The reactivities of anti-Ki sera to those synthetic peptides were tested by ELISA.Eighteen out of 49 sera reacted with KILT but none of them strongly reacted with KISP1-4. The KILT specifically reacted with anti-Ki sera but did not react with autoantibodies to other nuclear antigens such as U1 RNP,Sm, SS-A,SS-B,PCNA,Scl-70 and Jo-1. In addition, the reactivity of anti-Ki antibodies to KILT was specifically inhibited by bNAX.Those results indicated that KILT specifically reacted with anti-Ki antibody. A 7-mer synthetic peptide that had the same sequence as that of SV 40 NLS (LTSP) was prepared to test the cross-reactivity between the Ki antigen and SV 40 large T antigen. Eight out of 49 sera reacted with it and 7 of them reacted with both LTSP and KILT.The frequency of sera reacted with LTSP in anti-KILT positive sera (38.8%) was significantly higher (P<0.01) compared with that in anti-KILT negative sera (3.2%). Those results suggest that anti-Ki antibodies from lupus patients recognize the amino acid sequence homologous to SV 40 NLS as an epitope and molecular mimicry between Ki and SV 40 large T antigen may play a possible role for autoantibody production.
编码核自身抗原KI的cDNA已被克隆,我们发现KI含有一个与SV-40大T抗原核定位标志(SV-40 NLS)同源的氨基酸序列。为探讨与SV 40 NMS同源的氨基酸序列是否是与SV 40大T抗原发生交叉反应的KI抗原表位和抗KI抗体的表位之一,以重组KI(BNAX)为抗原,采用酶联免疫吸附试验(ELISA)从250例系统性红斑狼疮(SLE)患者中筛选出49份抗KI阳性血清。制备了一种与SV 40NLS(Kirt)序列同源的16聚KI合成肽。此外,通过对KI抗原的构象分析和杂化分析,制备了4种不同的合成肽(KISP1-4)。用ELISA检测了抗KI血清与合成肽的反应性,49份血清中有18份与KIRT反应,但没有一份与KISP1-4发生强烈反应。该短裙可与抗KI血清特异反应,但不与U1RNP、Sm、SS-A、SS-B、PCNA、SCL-70和Jo-1等核抗原自身抗体反应。此外,抗KIL抗体对KILT的反应性被bNAX特异性抑制,表明KILT与抗KI抗体发生了特异性反应。制备了一个与SV 40 NLS(LTSP)序列相同的7聚体合成肽,用于检测KI抗原与SV 40大T抗原的交叉反应。在49份血清中有8份与LTSP反应,其中7份同时与LTSP和KILT反应。抗kirt阳性血清与LTSP反应的频率(38.8%)显著高于抗kirt阴性血清(3.2%)(P&lt;0.01)。这些结果提示,狼疮患者抗KI抗体可识别与SV 40 NLS同源的氨基酸序列作为表位,KI与SV 40大T抗原之间的分子模拟可能对自身抗体的产生起作用。

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takasaki Y,Yamanaka K,Nikaido T,Shimada K,Shibata M,Hashimoto H,Hirose S: "An epitope on Ki antigen recognized by autoantibodies from lupus patients is homologous to SV 40 large T antigen nuclear localization sign." Mol Biol Rep. 15. 216 (1991)
Takasaki Y、Yamanaka K、Nikaido T、Shimada K、Shibata M、Hashimoto H、Hirose S:“狼疮患者自身抗体识别的 Ki 抗原上的表位与 SV 40 大 T 抗原核定位标志同源。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H Hashimoto,M Sugawara,Y Tok〓〓 M Sakamoto,Y Isobe,Y Takasaki,K Karasawa,I Hirose: "Follow up study of the changes in the clnical features and prognosis of Japanese patients with systemic lupus ery the matosus cluring the past 3to4 decades." J.Epidemiol.3.
H Hashimoto,M Sukawara,Y Tok〓 M Sakamoto,Y Isobe,Y Takasaki,K Karasawa,I Hirose:“日本系统性狼疮患者临床特征和预后变化的跟踪研究3 至 4 十年。”J.Epidemiol.3。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takasaki,Y.,Yamanaka,K.,Nikaido,T.,Shimada,K.,Shibata,M.,Hashimoto,H.,and Hirose,S.: "An epitope on Ki antigen recognized by antoantibodies from lupus patients is homologous to SV40 large T antigen muclear localization sign" Molec.Biol.Rep.15. 216-216 (19
Takasaki,Y.、Yamanaka,K.、Nikaido,T.、Shimada,K.、Shibata,M.、Hashimoto,H. 和 Hirose,S.:“狼疮患者的抗体识别的 Ki 抗原上的表位是同源的
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hashimoto H,Sugawara M,Tokano Y,Sakamoto M,Isobe Y,Takasaki Yet al: "Follow up study of the changes in the clinical features and prognosis of Japanes patients with systemic lupus erytematosus during the 4 decades." J Epidemiol. 3. 19-27 (1993)
Hashimoto H,Sukawara M,Tokano Y,Sakamoto M,Isobe Y,Takasaki Yet al:“40年来日本系统性红斑狼疮患者临床特征和预后变化的跟踪研究”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
高崎芳成: "最新内科学大系24膠原病と類縁疾患、抗核抗体" 中山書店, 624 (1993)
高崎吉成:《最新内科24种胶原蛋白疾病及相关疾病、抗核抗体》中山书店,624(1993)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TAKASAKI Yoshinari其他文献

Phenotype conversion from RA to SLE in FcγRIIB-deficient B6 mice by Yaa mutation
Yaa 突变导致 FcγRIIB 缺陷 B6 小鼠从 RA 向 SLE 的表型转变
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    KAWANO Shinya;AMANO Hirofumi;LIN Qingshun;KANEKO Toshiyuki;NISHIKAWA Keiko;OKAZAKI Hideki;TSURUI Hiromichi;NISHIMURA Hiroyuki;SHIRAI Toshikazu;TAKASAKI Yoshinari;HIROSE Sachiko.
  • 通讯作者:
    HIROSE Sachiko.

TAKASAKI Yoshinari的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TAKASAKI Yoshinari', 18)}}的其他基金

Effect of SLAM mutation and activating and inhibitory FcR on autoimmune prone mice
SLAM突变及激活和抑制FcR对自身免疫易感小鼠的影响
  • 批准号:
    26461474
  • 财政年份:
    2014
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Association of linkage between autoantigens and, ubiquitin. proteasome system in autoantibody production
自身抗原和泛素之间的联系。
  • 批准号:
    21591271
  • 财政年份:
    2009
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of relationship between autoimmune response and, structure and function of proteasome-PCNA multiprotein complex
自身免疫反应与蛋白酶体-PCNA多蛋白复合物结构和功能关系分析
  • 批准号:
    16590995
  • 财政年份:
    2004
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of structure of proteasome-PCNA multiprotein conplex and its autoimmune response
蛋白酶体-PCNA多蛋白复合物结构分析及其自身免疫反应
  • 批准号:
    13670476
  • 财政年份:
    2001
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of a novel RNA epitope recognized by sera in patients with rheumatic diseases using randomized RNA epitope library
使用随机 RNA 表位库分析风湿性疾病患者血清识别的新 RNA 表位
  • 批准号:
    10670427
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Distinct Glycophenotypes with Abnormal Signaling Define a Subpopulation of B cells Responsible for Production of Galactose-Deficient IgA1, the Main Autoantigen in IgA Nephropathy
具有异常信号传导的独特糖表型定义了负责产生半乳糖缺陷型 IgA1(IgA 肾病的主要自身抗原)的 B 细胞亚群
  • 批准号:
    10563618
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Insights into erythropoietin homeostasis: Identifying the autoantigen targeted in the TEMPI syndrome
深入了解促红细胞生成素稳态:识别 TEMPI 综合征中针对的自身抗原
  • 批准号:
    10511508
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Single-cell analysis of autoantigen-reactive B cells in systemic sclerosis and development of novel therapeutic targets
系统性硬化症中自身抗原反应性 B 细胞的单细胞分析和新治疗靶点的开发
  • 批准号:
    22K16258
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Insights into erythropoietin homeostasis: Identifying the autoantigen targeted in the TEMPI syndrome
深入了解促红细胞生成素稳态:识别 TEMPI 综合征中针对的自身抗原
  • 批准号:
    10661092
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Identification of a true extracellular autoantigen that cross-reacts with autoantibodies in systemic sclerosis.
鉴定与系统性硬化症中的自身抗体发生交叉反应的真正的细胞外自身抗原。
  • 批准号:
    21K19472
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Characterisation of autoantigen-specific human B cells in central nervous system autoantibody-mediated diseases
中枢神经系统自身抗体介导疾病中自身抗原特异性人 B 细胞的表征
  • 批准号:
    MR/V007173/1
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Fellowship
Oral autoantigen therapy for the treatment of Multiple Sclerosis
口服自身抗原疗法治疗多发性硬化症
  • 批准号:
    10331867
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Oral autoantigen therapy for the treatment of Multiple Sclerosis
口服自身抗原疗法治疗多发性硬化症
  • 批准号:
    10157209
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Analysis of the effect of cytokine production by autoantigen-reactive B cells in systemic sclerosis on other immune systems.
分析系统性硬化症中自身抗原反应性 B 细胞产生细胞因子对其他免疫系统的影响。
  • 批准号:
    20K22925
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Elucidation of pathophysiology and establishment of new diagnostic system for IgG4-related disease by autoantigen identification
通过自身抗原鉴定阐明 IgG4 相关疾病的病理生理学并建立新的诊断系统
  • 批准号:
    19H03698
  • 财政年份:
    2019
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了